Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Relevium Technologies Inc. (V:RLV)

Business Focus: Special Foods & Welbeing Products

Jun 23, 2020 03:49 pm ET
Relevium Issues Important Clarification About Bioganix CleanCare Brand
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an important clarification about Bioganix CleanCare, its brand of disinfection and wellness products. On. June 19,...
Jun 23, 2020 09:15 am ET
Relevium Welcomes Award-Winning Marketing Executive to Its Advisory Board
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the appointment of Mr. James Mansour, an award-winning brand and marketing executive to its advisory board. Mr....
Jun 19, 2020 12:19 pm ET
Relevium Expands CleanCare Offering as International Organizations Call for Increased Institutional and Government Stockpile of Supplies
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has expanded and continues to expand its CleanCare™ product line as it prepares to address increased government...
Jun 11, 2020 01:45 pm ET
Relevium Successfully Delivers Initial Orders of Cleancare™ Products to Retail Customers
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the successful delivery of Cleancare™ Hand Sanitizers to retail customers in the in the US, including the orders...
Jun 02, 2020 11:12 am ET
Relevium Provides Regulatory Update on Previously Announced Initiatives and Transactions
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), as a requirement in order to obtain final regulatory approval for its private placement as announced on Monday May 25, 2020, is pleased to...
May 27, 2020 05:11 pm ET
Relevium Announces Delayed Filing of Interim Disclosure Documents Pursuant to Temporary Relief Granted by Regulators due to COVID-19
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), today announced that it will be delaying the filing and delivery of certain of its continuous disclosure documents, in accordance with...
May 25, 2020 03:50 pm ET
Relevium Announces $1.8M Private Placement and Closing
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce today a private placement offering of up to 58,000,000 units (the “Units”) of the Company at a price of $0.035 per...
Apr 24, 2020 11:45 am ET
Relevium Expands CleanCare™ Hand Sanitizer Formats and Supply Capabilities; Company Targets Retirement Homes and Community Centers
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today that its expanding its CleanCare™ hand sanitizing line to include two new retail formats as well as one new...
Apr 20, 2020 12:00 pm ET
Relevium to Present at Mi3 Online Investor Webinar
Relevium Technologies Inc. (TSX.V:“RLV”, OTC:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company will be presenting at the Mi3 Investor and Broker Video Conference this Friday April 24th at 12:00PM...
Apr 15, 2020 10:28 am ET
Relevium Reports $250,000 in Pre-Sales for Bioganix® CleanCare Hand Sanitizers in First 6 Days
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today that its new line of Bioganix® CleanCare hand sanitizers has been met with very strong pre-sales demand of...
Apr 13, 2020 10:32 am ET
RELEVIUM TO LAUNCH PHOTOCATALYTIC UV AIR PURIFICATION SYSTEM FOR BIOGANIX® CLEANCARE LINE
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today it has partnered with Montreal based air purification leaders to launch a new line of residential and office...
Apr 09, 2020 12:36 pm ET
RELEVIUM LAUNCHES PRE-ORDER OF BIOGANIX® CLEANCARE HAND SANITIZERS IN CANADA AND USA
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company has launched its newly launched Bioganix® CleanCare hand sanitizer product on pre-order to consumers...
Apr 08, 2020 03:44 pm ET
RELEVIUM TO PRESENT AT Mi3 ONLINE INVESTOR WEBINAR
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company will be presenting at the Mi3 Investor and Broker Video Conference this Friday April 10th at 1:30PM...
Apr 08, 2020 11:02 am ET
RELEVIUM SECURES NPN NUMBER WITH MANUFACTURING PARTNER AND IS READY TO MARKET BIOGANIX® CLEANCARE HAND SANITIZERS IN CANADA
Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has secured the natural product number (“NPN”) for the Canadian market and is ready to launch the product for...
Apr 06, 2020 11:03 am ET
Relevium Launches Pre-Order of Bioganix® Cleancare Hand Sanitizers
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today that a pre-order platform where customers can purchase in advance and reserve its new line of Cleancare hand...
Apr 02, 2020 11:01 am ET
RELEVIUM TO COMMERCIALIZE BIOGANIX® CLEANCARE HAND SANITIZERS
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today it has sourced and will begin commercializing a line of Bioganix® hand sanitizers. Relevium is leveraging...
Mar 04, 2020 11:40 am ET
Relevium Announces the Passing of Dr. Tina Sampalis, Director and Scientific Officer
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is announces the passing of Dr. Tina Sampalis, Director and Scientific Officer of the Company. It is with heavy hearts and great sadness...
Mar 03, 2020 11:45 am ET
Relevium Ships First Purchase Order Release of $130,000 to Middle East Customer
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the Company’s subsidiary, BGX E-Health LLC (“BGX”), has shipped a total of CAD $130,000 worth of generic...
Mar 02, 2020 08:30 am ET
Relevium Reports Improved Financial Results for Second Quarter of Fiscal 2020  
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report second quarter results for fiscal year ending June 30, 2020. Financial highlights for the second quarter of 2020...
Feb 05, 2020 08:10 am ET
Relevium Announces Update Call for Shareholders
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce a shareholder information video-conference call to provide an update on the current business and ongoing...
Jan 28, 2020 09:15 am ET
Relevium Provides Update on Newscope Transacion
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an update on the proposed transaction with Newscope Capital. As announced in a letter from the CEO issued on...
Dec 19, 2019 09:14 am ET
Relevium’s CEO Provides an Open Shareholder Letter for 2020
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide an open letter to its shareholders from the company’s Chief Executive Officer, Aurelio Useche. Dear valued...
Nov 20, 2019 09:18 am ET
Relevium Launches LeefyLyfe™ Organic Hemp Products in the US
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the launch of LeefyLyfeTM Organics, a comprehensive line of organic health and wellness products formulated with...
Nov 08, 2019 08:35 am ET
Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a letter of intent to acquire a Montreal based biopharma contract manufacturing company through its...
Nov 07, 2019 09:11 am ET
Relevium Technologies Appoints Mark Billings as Chief Financial Officer
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the appointment of Mark Billings, CFA as Chief Financial Officer for both Relevium and Biocannabix Health...
Oct 30, 2019 09:30 am ET
Relevium’s Subsidiary BGX E-Health Secures One Million Dollar Export Contract for the Middle East
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned subsidiary, BGX E-Health LLC (“BGX”), has received a purchase order to supply Innova Health...
Oct 29, 2019 09:22 am ET
Relevium Enters Into LOI to Unlock Value of Wholly Owned Subsidiary BGX E-Health LLC and Announces Conference Call With CEO
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce On October 25, 2019, the Company received a letter of intent (the “LOI”) to roll its interest in its wholly owned...
Oct 17, 2019 08:30 am ET
Relevium Acquires 100% of Late Stage Processing and Medical Sales Applicant Weedsense
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly- owned subsidiary, Biocannabix (“BCX”), has executed an Agreement (the “Agreement”) to acquire 100% of...
Oct 09, 2019 03:05 pm ET
Relevium Enters Into Manufacturing Agreement With Bio V Pharma and Registers 400 NPN Numbers With Health Canada  
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce today that it has registered four hundred (400) Natural Product Numbers (NPNs) with Health Canada through its main...
Sep 19, 2019 08:34 am ET
Relevium Announces Intention to Spin-Out Pediatric Cannabis Subsidiary Biocannabix
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces its intention to create a new, publicly-traded company through a spin-out of its pediatric, medical cannabis subsidiary,...
Sep 11, 2019 09:18 am ET
Relevium Announces Results of Annual Meeting of Shareholders and Updates Other Regulatory Matters
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the results of the Company's annual general and special meeting (the "AGM") held on September 6, 2019, in Montreal,...
Aug 01, 2019 09:41 am ET
Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company hit a record high in monthly sales in the month of July 2019 for its Bioganix® branded OTC...
Jul 10, 2019 09:30 am ET
Relevium Signs Exclusivity Agreement With SOSCannabis.com for Reimbursement for Pediatric Patients
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has executed an exclusivity agreement to partner with SOS cannabis Inc. (“SOSCannabis”), which will provide pediatric...
Jul 03, 2019 10:03 am ET
Relevium’s CEO Issues Letter of Clarification to Shareholders  
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today a letter from Aurelio Useche, CEO to shareholders to clarify misconceptions and rumours in the market about a compliance...
Jul 01, 2019 04:24 pm ET
Relevium Issues Statement Regarding Recent Promotional Activity
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today that it has been made aware of and requested by the OTC Markets Group, Inc. to comment on recent promotional activity...
Jun 26, 2019 04:00 am ET
Relevium’s Biocannabix Positions Itself as an Important Player in Colombia as it Pursues Endo-Medical Cannabis Strategy for Latin America
Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or “Relevium”) announced today it is positioning itself as an important player in the Colombian medical...
Jun 19, 2019 08:30 am ET
Relevium to Hold Investor Call to Discuss LATAM Strategy June 28, 2019 at 1:00pm EST
Relevium Technologies Inc. a Health and Wellness portfolio company listed on TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX” (the “Company” or “Relevium”), is pleased to announce it will be holding a shareholder and investor conference call to...
Jun 13, 2019 01:04 pm ET
IIROC Trading Resumption - RLV
VANCOUVER, June 13, 2019 /CNW/ - Trading resumes in:
Jun 13, 2019 09:54 am ET
Relevium Takes Major Step in Latam to Acquire Lifeline Pharma in Cali, Colombia
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that Biocannabix Health Corporation (“Biocannabix”), a wholly-owned subsidiary of Relevium has executed on June 12,...
Jun 13, 2019 08:28 am ET
IIROC Trading Halt - RLV
VANCOUVER, June 13, 2019 /CNW/ - The following issues have been halted by IIROC:
Jun 11, 2019 05:51 pm ET
Relevium Closes Private Placement Financing
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has closed a non-brokered private placement financing for a total of 15,350,000 units (the "Units") at...
Jun 05, 2019 09:46 am ET
Relevium’s Biocannabix Executes LOI to Acquire 30% Interest in Weedsense, a Late Stage Applicant for Standard Processing and Medical Sales License
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce its wholly owned subsidiary Biocannabix Health Corporation (“Biocannabix”) has executed an LOI to acquire 30% of...
Jun 03, 2019 11:31 am ET
Relevium Provides Corporate Update on Its Medical Cannabis Strategy
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide a corporate update on the Company’s positioning and strategy regarding medical cannabis and CBD Nutraceuticals....
May 30, 2019 08:00 am ET
Relevium Acquires Exclusive Licence From California Based Cannakids®
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned subsidiary Biocannabix Health Corporation Inc., has completed necessary compliance process and...
May 24, 2019 09:29 am ET
Relevium Launches New Line of High-End Omega Fish Oils Targeting Inflammation, Heart and Vision    
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its OTC business has launched a new line of omega fish oils based formulations targeting inflammation, heart and...
May 21, 2019 10:24 am ET
IIROC Trading Resumption - RLV
VANCOUVER, May 21, 2019 /CNW/ - Trading resumes in:
May 21, 2019 08:30 am ET
Relevium Announces Private Share Purchase by CEO
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today that Mr. Aurelio Useche, Chief Executive Officer, has agreed to purchase a total of 4,213,713 common shares of Relevium,...
May 21, 2019 08:28 am ET
IIROC Trading Halt - RLV
VANCOUVER, May 21, 2019 /CNW/ - The following issues have been halted by IIROC:
May 21, 2019 07:05 am ET
Albertus P. Engelbrecht Files Early Warning Report
MONTREAL, QUEBEC / TheNewswire / May 21, 2019 – Mr. Albertus P. Engelbrecht on 9 Heron Street Durbanville, Cape Town, 7550, Western Cape, South Africa (the “Shareholder”) announces the filing of an early warning report in connection with the disposition of 4,213,713 common shares in the capital of Relevium Technologies Inc. (the "Issuer"). The shares were disposed of on May 21, 2019 through a private sale between the Shareholder and the Issuer’s Chief Executive Officer, Mr. Aurelio Useche, for an amount of CAD$547,782, equivalent to CAD$0.13 per common share.
May 17, 2019 09:27 am ET
Relevium Announces Reprice of the 2016 and 2017 Series Warrants
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced the re-pricing 12,398,500 warrants series 2017 with an original exercise price of $0.15 and expiring June 16, 2019 and 3,258,000...
Mar 01, 2019 08:53 am ET
Relevium Reports Second Quarter Revenue Bounce Back for Fiscal 2019  
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report second quarter results for fiscal 2019. Financial highlights for the second quarter of 2019 During the second...
Feb 13, 2019 08:00 am ET
Walmart’s Influence in the Healthcare Sector; Spreading Health and Wealth as Vendors Capitalize on Spending
Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at increased quarterly sales for the sector thanks, in no small part, to Walmart. CNBC has reported on how Walmart is looking...
Feb 08, 2019 02:42 pm ET
Relevium Announces DTC Eligibility for the US Market
Relevium Technologies Inc. (TSX.V: “RLV”,  OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce it has secured eligibility by The Depository Trust Company (DTC) for its shares on the OTC. DTC is a subsidiary of...
Feb 07, 2019 08:31 am ET
Relevium Launches the Push and Pull System™, Targeting a New Revenue Stream in the Burgeoning Cosmeceutical Market
Relevium Technologies Inc. (TSX.V: “RLV”,  OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the new launch of the Push and Pull System™, an innovation in delivering a comprehensive solution for skin care,...
Jan 29, 2019 10:01 am ET
Relevium Announces Investor Web Conference
Relevium Technologies Inc. (TSX.V: “RLV”,  OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it will be hosting a town hall webcast on February 8th 2019 after market hours at 16:30 EST to discuss the...
Jan 23, 2019 08:30 am ET
Relevium to Acquire Multi-Brand Company in the UK
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a binding agreement to acquire 100% of the shares of Sleipnir Nutrition Ltd. (“Sleipnir”), a UK...
Jan 15, 2019 02:13 pm ET
Relevium To Host Screenings of Documentary “Weed The People” Across Canada Today -- CFN Media
via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF”...
Jan 10, 2019 03:38 pm ET
Relevium Announces the National Screening of “Weed the People” Movie Across Eight Major Cities
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the national screening of “Weed the People” across eight Canadian cities on January 15, 2019. Relevium Technologies,...
Jan 03, 2019 11:01 am ET
Clarification: Albertus P. Engelbrecht Files Early Warning Report
MONTREAL, QUEBEC / TheNewswire / January 3, 2019 - Mr. Albertus P. Engelbrecht on 9 Heron Street Durbanville, Cape Town, 7550, Western Cape, South Africa (the “Shareholder”) announces the filing of an early warning report in connection with his holdings in the capital of Relevium Technologies Inc. (the "Issuer").
Jan 03, 2019 07:01 am ET
Albertus P. Engelbrecht Files Early Warning Report
MONTREAL, QUEBEC / TheNewswire / January 3, 2019 – Mr. Albertus P. Engelbrecht on 9 Heron Street Durbanville, Cape Town, 7550, Western Cape, South Africa (the “Shareholder”) announces the filing of an early warning report in connection with his holdings in the capital of Relevium Technologies Inc. (the "Issuer").
Dec 13, 2018 04:49 pm ET
Relevium Provides Corporate Update
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide shareholders with a corporate update on the previously announced transaction with CannaKids and CK properties, as well...
Dec 13, 2018 09:48 am ET
Relevium Launches Its Leefylyfe™ Organically Sourced Whole Plant Hemp Derived CBD Products in the UK
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has launched its  Leefylyfe™ brand of organically sourced full spectrum hemp CBD products on a pre-order...
Dec 12, 2018 09:41 am ET
Relevium Launches 30 New Bioganix® Gold Brand Products in Walmart.com
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that it has launched 30 new exclusive products under its Bioganix® Gold Brand in Walmart.com On October 11, 2018,...
Dec 05, 2018 09:00 am ET
Relevium Adds Amazon Experts to the Team
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce it has retained Rohan Mendonza and his company, NForce Labs Inc., to lead its Amazon business. Rohan Mendonza,...
Nov 30, 2018 09:41 am ET
Relevium Technologies Provides Corporate Update and Summarized First Quarter Results
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to provide a corporate update and summarized discussion on the results for its first quarter. Cannakids License for Canada...
Nov 15, 2018 02:07 pm ET
Relevium Technologies Signs JV With Holistic Industries for Biocannabix Health Corporation
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce it has executed a letter of intent to form a partnership with Holistic Industries to jointly develop Biocannabix...
Oct 29, 2018 09:32 am ET
Relevium Technologies Provides Corporate Update and Fiscal Year End Results
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to provide a corporate update and summarized discussion on the results for its first year of operations since the acquisition of...
Oct 26, 2018 09:40 am ET
Relevium Technologies Announces Conversion of Debentures and Strenghtens Balance Sheet
Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has received notices to convert (the "Conversion") all of the principal amount outstanding of the remaining...
Oct 16, 2018 08:30 am ET
Relevium Announces Strategic Investment in Leading Pediatric Cannabis Company and Obtains Exclusive License for the Canadian Market
Relevium Technologies Inc. (TSX.V:  “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it has executed a binding letter of intent for a strategic investment into CannaKids.org for an initial 25%...
Oct 11, 2018 09:46 am ET
Relevium Targets 30 New Bioganix® Gold Products in Walmart by Year End and Prepares to Launch in Canada
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced its plans to increase its presence in Walmart.com and ramp up its current offering to over thirty (30) SKUs before the end of...
Oct 02, 2018 11:38 am ET
At the Request of IIROC Relevium Unaware of Any Material Changes
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), at the request of IIROC (Investment Industry Regulatory Organization of Canada) wishes to confirm that the Company’s management is unaware...
Sep 20, 2018 09:20 am ET
Relevium’s Bioganix® Now Live on Amazon.co.uk   
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce that the Bioganix® brand is now available for purchase in the United Kingdom (“UK”) on the Amazon.co.uk platform....
Sep 18, 2018 08:35 am ET
Relevium Set to Launch Organic Hemp CBD Product Line in the Fall
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that it will be launching its first organic whole hemp extract product line under the LeefyLyfe® brand in Europe...
Sep 05, 2018 08:33 am ET
Relevium’s Biocannabix Subsidiary Signs Lease Agreement for Its ACMPR Facility
Relevium Technologies Inc. (TSX.V:  “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the company’s wholly owned subsidiary Biocannabix (“BCX”) has signed a lease agreement for the company’s...
Aug 21, 2018 08:00 am ET
Relevium Launches 5 New Bioganix® Products
Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that the Company has just launched five new Bioganix® products which are now live on both the native websites at...
Jul 30, 2018 08:45 am ET
Relevium’s Bioganix® Gold Series Nutraceuticals Live on Walmart.com
Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) and (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has received final listing approval for its Bioganix® Gold Series Nutraceuticals on Walmart.com and the products are...
Jul 19, 2018 08:00 am ET
Relevium’s Biocannabix Receives City Approval for Medical Cannabis Facility
Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) and (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that the company’s wholly owned subsidiary Biocannabix Health Corporation (“BCX”) has received an approval letter from...
Jul 05, 2018 08:00 am ET
Relevium Secures CBD Supply Agreement for European Market
Relevium Technologies Inc. (TSX-V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has executed a supply agreement with Plena Global Holdings Inc., a Canadian based holding company accumulating medical...
Jun 15, 2018 11:37 am ET
Relevium Starts Production of Two Exclusive Formulations With Patented Provinal® Omega 7
Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) and (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has put into production 920,000 soft-gels each of its Cardio-Metabolic Syndrome and Dry-Eye Syndrome formulations...
Jun 08, 2018 08:17 am ET
Relevium Reduces Liabilities by $2 Million Through Conversion of Debenture Well Ahead of Maturity
Relevium Technologies Inc. (TSX-V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce the reduction of CAD $2 million in debt through the conversion (the “Conversion”) of the entire principal amount of USD...
Jun 08, 2018 07:06 am ET
Albertus P. Engelbrecht Files Early Warning Report
MONTREAL, QUEBEC / TheNewswire / June 8, 2018 – Pursuant to the terms of the convertible note between Relevium Technologies Inc. (the “Issuer”) and Mr. Albertus P. Engelbrecht, completed on June 8, 2018 (the “Closing Date”), Mr. Engelbrecht has acquired direct ownership (the “Acquisition”) of an aggregate of 14,587,688 common shares (the “Acquired Shares”) in the capital of Relevium Technologies Inc. (the “Issuer”).
Jun 04, 2018 09:13 am ET
Relevium Selects 93,000 Sq. Ft Organic Cultivation Facility in Quebec
Relevium Technologies Inc. (TSX-V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that, through its wholly-owned subsidiary Biocannabix (“BCX”), it has selected a 93,000 square foot facility in Montreal,...
May 30, 2018 12:19 pm ET
Relevium Announces Revenue of $3.2M for the Nine-Month Period Ended March 31, 2018
Relevium Technologies Inc. (TSX-V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”) is pleased to announce its financial and operating results for the three and nine months’ period ended March 31, 2018. Highlights Nine-month sales...
May 25, 2018 08:22 am ET
Relevium Appoints New CFO to Drive Performance  
Relevium Technologies Inc. (TSX-V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has appointed Mr. Faycal Salek CPA, CA as the Chief Financial Officer of the Company effective immediately. Mr. Salek is...
May 17, 2018 08:00 am ET
Relevium Engages PipeDreemz as Lead ACMPR Consultant for Biocannabix   
Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce it has engaged PipeDreemz as lead consultant (the “Consultant”) for the Biocannabix Health Corp (“BHC”) ACMPR applications to...
May 03, 2018 09:02 am ET
Relevium Launches Bioganix® on Walmart.com   
Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that it has received approval to sell its biggest mover Bioganix® products on Walmart.com. Highlights New and diverse...
Apr 30, 2018 11:20 am ET
Relevium Announces Agreement with Neptune Wellness for MaxSimil®
MONTREAL, April 30, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:RLV), (OTCQB:RLLVF) and (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce the signing of a product development, supply and commercialization agreement with Neptune Wellness Solutions (TSX:NEPT) (NASDAQ:NEPT) for...
Apr 26, 2018 08:58 am ET
Relevium Creates Cannabis Brands for North-American Market
MONTREAL, April 26, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:RLV) (OTCQB:RLLVF) (Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce the creation of its two first cannabis brands, LeefyLyfe and Biocannabix offering cannabis products in the North-American and European...
Apr 19, 2018 10:14 am ET
Relevium Creates Biocannabix Subsidiary and Targets Legal Cannabis Business   
MONTREAL, April 19, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX VENTURE:RLV) (OTCQB:RLLVF) (FRANKFURT:6BX) (the “Company” or “Relevium”), is pleased to announce the creation of Biocannabix Health Corporation (the “Subsidiary” or “BHC”), a Canadian wholly owned subsidiary structured to...
Apr 05, 2018 01:37 pm ET
Relevium Targets 83 Million Unique Monthly Visitors and 26 Countries Through European Expansion of Bioganix(R)
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce that it has started the process of establishing European presence for the new Bioganix(R) brand in partnership with several online partners, including Amazon. Management will be doing an initial launch of eight best selling products, which will be live online on the week of the May 21, 2018 with full marketing launch by mid summer.
Apr 05, 2018 01:37 pm ET
Relevium Targets 83 Million Unique Monthly Visitors and 26 Countries Through European Expansion of Bioganix(R)
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce that it has started the process of establishing European presence for the new Bioganix® brand in partnership...
Apr 03, 2018 09:00 am ET
Relevium Announces All-Time Record High of Units Sales for Bioganix(R) in March
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to report an all-time record high in unit sales for the month of March 2018.
Apr 03, 2018 08:58 am ET
Relevium Announces All-Time Record High of Units Sales for Bioganix(R) in March
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to report an all-time record high in unit sales for the month of March 2018. The reported record high of 16,549 units,...
Mar 29, 2018 10:26 am ET
Relevium Launches New Bioganix Brand Architecture
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce it has completed the re-positioning of its Bioganix brand. The new re-positioning enhances Bioganix around the key branding points of Credibility, Quality and Trust. The Company will be rolling out its new brand and new packaging immediately.
Mar 29, 2018 10:26 am ET
Relevium Launches New Bioganix Brand Architecture
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce it has completed the re-positioning of its Bioganix brand. The new re-positioning enhances Bioganix around the key...
Mar 13, 2018 09:00 am ET
Relevium Announces Initial Launch of Hempco's PlanetHemp® in the USA
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) ("Relevium") and Hempco Food and Fiber Inc (TSX VENTURE: HEMP) ('Hempco') are pleased to announce the launch of five PlanetHemp(R) products in the U.S., which are expected to be live the week of March 19, 2018.
Mar 13, 2018 08:58 am ET
Relevium Announces Initial Launch of Hempco's PlanetHemp® in the USA
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) ("Relevium") and Hempco Food and Fiber Inc (TSX VENTURE:HEMP) ('Hempco') are pleased to announce the launch of five PlanetHemp® products in the U.S., which are...
Mar 07, 2018 10:58 am ET
Relevium Launches New Aloe Vera Based Products
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce it has entered into an agreement with Curaçao Ecocity Projects N.V. to conduct a soft launch of an exclusive...
Mar 07, 2018 10:58 am ET
Relevium Launches New Aloe Vera Based Products
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce it has entered into an agreement with Curacao Ecocity Projects N.V. to conduct a soft launch of an exclusive line of Aloe Vera based supplements and skin care products under the Bioganix(R) brand.
Mar 05, 2018 11:11 am ET
Relevium Appoints Mr. Didier Martin as Blockchain Lead Expert
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF) and (FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce it has appointed Mr. Didier Martin as special advisor and project leader for the Company's current and future...
Mar 05, 2018 11:11 am ET
Relevium Appoints Mr. Didier Martin as Blockchain Lead Expert
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF) and (FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce it has appointed Mr. Didier Martin as special advisor and project leader for the Company's current and future Blockchain projects.
Mar 02, 2018 11:08 am ET
Relevium Provides H2 Guidance for Bioganix, Acquisitions and Legal Hemp Derivatives
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to provide guidance on its strategy for its core e-commerce business for the second half of fiscal year ending June 30, 2018.
Mar 02, 2018 11:08 am ET
Relevium Provides H2 Guidance for Bioganix, Acquisitions and Legal Hemp Derivatives
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to provide guidance on its strategy for its core e-commerce business for the second half of fiscal year ending June 30, 2018....
Mar 01, 2018 04:01 pm ET
Relevium Announces Revenue of $2.1M for the Six-Month Period Ended December 31, 2017
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce the results for the three and six months ended December 31, 2017. Financial and Operating Highlights for the...
Mar 01, 2018 04:01 pm ET
Relevium Announces Revenue of $2.1M for the Six-Month Period Ended December 31, 2017
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce the results for the three and six months ended December 31, 2017.
Feb 23, 2018 12:37 pm ET
Relevium Clarifies Operational Update
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to provide further clarifications on its press release from earlier today.
Feb 23, 2018 12:37 pm ET
Relevium Clarifies Operational Update
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to provide further clarifications on its press release from earlier today. The Company has received several requests...
Feb 23, 2018 09:00 am ET
Relevium Operational Update and Investments for Financial H1 2018
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is reporting on an operational update and areas of investment for financial Q2 2018 (October 1, 2017 to December 31, 2017).
Feb 23, 2018 08:58 am ET
Relevium Operational Update and Investments for Financial H1 2018
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is reporting on an operational update and areas of investment for financial Q2 2018 (October 1, 2017 to December 31, 2017). Aurelio...
Feb 20, 2018 10:56 am ET
Relevium Commences Trading on OTCQB
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce that it has commenced trading on the OTCQB under the symbol RLLVF
Feb 20, 2018 10:56 am ET
Relevium Commences Trading on OTCQB
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce that it has commenced trading on the OTCQB under the symbol RLLVF Aurelio Useche, President and CEO...
Feb 16, 2018 03:38 pm ET
Relevium Announces 2018 AGM Results
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce the positive results from its annual and special meeting held on February 15, 2018 in Montréal, Canada (the "AGM")....
Feb 16, 2018 03:38 pm ET
Relevium Announces 2018 AGM Results
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTCQB: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce the positive results from its annual and special meeting held on February 15, 2018 in Montreal, Canada (the "AGM").
Feb 05, 2018 09:47 am ET
Relevium Improves Financial Position and Provides Updates on Warrants Exercises and Share for Services Agreement
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to report improvements on its financial position, provide an update on warrants exercised to date and on shares issued to its corporate secretary on a share for services agreement.
Feb 05, 2018 09:47 am ET
Relevium Improves Financial Position and Provides Updates on Warrants Exercises and Share for Services Agreement
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to report improvements on its financial position, provide an update on warrants exercised to date and on shares issued to its corporate...
Jan 18, 2018 03:14 pm ET
Relevium to Host Webcast to Discuss Previously Announced Blockchain Project
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTC PINK:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce that it will be hosting a webcast in conjunction with Quantomic LLC to discuss Tagspire, the virtual intelligent...
Jan 18, 2018 03:14 pm ET
Relevium to Host Webcast to Discuss Previously Announced Blockchain Project
Relevium Technologies Inc. (TSX VENTURE: RLV)(OTC PINK: RLLVF)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce that it will be hosting a webcast in conjunction with Quantomic LLC to discuss Tagspire, the virtual intelligent e-retail platform and artificial intelligence technology stack.
Jan 11, 2018 08:48 am ET
IIROC Trade Resumption - Relevium Technologies Inc
Vancouver, British Columbia--(Newsfile Corp. - January 11, 2018) - Trading resumes in:
Jan 11, 2018 07:54 am ET
IIROC Trading Resumption - PRV.UN; RLV; LMR; UI
VANCOUVER, Jan. 11, 2018 /CNW/ - Trading resumes in:
Jan 11, 2018 07:00 am ET
Relevium Signs JV for E-Commerce AI With Blockchain Technology Integration, Proposes Initial Coin Offering
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce the signing of a joint venture agreement ("JV") with Quantomic LLC (the "Parties") for Tagspire, a virtual retail and visual commerce platform.
Jan 11, 2018 06:58 am ET
Relevium Signs JV for E-Commerce AI With Blockchain Technology Integration, Proposes Initial Coin Offering
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce the signing of a joint venture agreement ("JV") with Quantomic LLC (the "Parties") for Tagspire, a virtual retail and visual commerce...
Jan 10, 2018 01:54 pm ET
IIROC Trade Halt - Relevium Technologies Inc
Vancouver, British Columbia--(Newsfile Corp. - January 10, 2018) - The following issues have been halted by IIROC:
Jan 10, 2018 12:57 pm ET
IIROC Trading Halt - RLV
VANCOUVER, Jan. 10, 2018 /CNW/ - The following issues have been halted by IIROC:
Jan 08, 2018 02:06 pm ET
Relevium Update On Shares-For-Services Agreement
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") announces that it has issued 38,935 shares today at a deemed price of $0.224733 per share to the Company's Corporate Secretary, Mr. David A. Johnson, pursuant to a shares-for-services agreement disclosed in a company press release dated October 20, 2017. The shares are subject to a four month hold period. Pricing was determined using the VWAP on the close of January 5, 2018, when submission to the TSX Venture Exchange approval was filed.
Jan 08, 2018 02:06 pm ET
Relevium Update On Shares-For-Services Agreement
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") announces that it has issued 38,935 shares today at a deemed price of $0.224733 per share to the Company's Corporate Secretary, Mr. David A. Johnson, pursuant...
Dec 22, 2017 04:27 pm ET
Relevium Update on Stock Option Plan and Option Issues
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce that the board of directors passed a resolution concerning changes to the Company's stock option plan presented at the Company's Annual...
Dec 19, 2017 02:19 pm ET
Relevium Update on Big Data / AI and Announces Webcast
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to provide an update on the Big Data /AI project as announced on September 7, 2017 and hosting of a webcast on December 21, 2017....
Dec 19, 2017 02:18 pm ET
Relevium Update on Big Data / AI and Announces Webcast
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to provide an update on the Big Data /AI project as announced on September 7, 2017 and hosting of a webcast on December 21, 2017.
Dec 12, 2017 07:00 am ET
Relevium Strengthens its Balance Sheet: Long-term Debt Down by $900,000, Cash Increases by Over $1,100,000
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), is pleased to announce it has strengthened its balance sheet through the partial conversion of debentures into equity, and increased its cash position through the exercise of warrants and options. The Company is also pleased to provide an update on the Non-Binding Letter of Intent ("LOI") announced October 25, 2017.
Dec 12, 2017 06:58 am ET
Relevium Strengthens its Balance Sheet: Long-term Debt Down by $900,000, Cash Increases by Over $1,100,000
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce it has strengthened its balance sheet through the partial conversion of debentures into equity, and increased its cash position...
Dec 06, 2017 07:00 am ET
Relevium Signs Exclusivity Agreement for Provinal Ultra-Purified Omega 7
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to announce the signing of an exclusive distribution agreement (the "Agreement") with Tersus Life Sciences for Provinal(R) C16:1n7 a patented, ultra-purified Omega 7 fatty acid blend .
Dec 06, 2017 06:58 am ET
Relevium Signs Exclusivity Agreement for Provinal Ultra-Purified Omega 7
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce the signing of an exclusive distribution agreement (the "Agreement") with Tersus Life Sciences for Provinal® C16:1n7 a...
Nov 30, 2017 12:00 am ET
Relevium Announces First Quarter Results With Revenues of $1.15million and 13% Adjusted EBITDA Margin
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to announce its unaudited financial results for the three-month period ended September 30, 2017.
Nov 29, 2017 11:58 pm ET
Relevium Announces First Quarter Results With Revenues of $1.15million and 13% Adjusted EBITDA Margin
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce its unaudited financial results for the three-month period ended September 30, 2017. Financial Highlights This is the...
Nov 23, 2017 01:16 pm ET
Relevium & HempCo Sign Exclusive Product Agreement for PlanetHemp
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly-traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce the signing of an exclusive brand and product assignment with HempCo Canada ("HempCo") for the Planet Hemp brand.
Nov 23, 2017 01:15 pm ET
Relevium & HempCo Sign Exclusive Product Agreement for PlanetHemp
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), a publicly-traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail...
Nov 06, 2017 09:09 am ET
Relevium Drives Top Line Growth for Q1
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce top line growth for Q1 in anticipation of its interim filings.
Nov 06, 2017 09:09 am ET
Relevium Drives Top Line Growth for Q1
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail...
Oct 31, 2017 12:01 am ET
Relevium Files and Provides Comments on the Audited Consolidated Financial Statements for the Fiscal Year Ended June 30, 2017 and 2016
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce the filing of the company's Audited Financial Statements and MD&A for the fiscal year ended June 30, 2017 and 2016 on Sedar
Oct 30, 2017 11:59 pm ET
Relevium Files and Provides Comments on the Audited Consolidated Financial Statements for the Fiscal Year Ended June 30, 2017 and 2016
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail...
Oct 27, 2017 03:21 pm ET
Relevium Provides Operational Progress Update and Appoints Senior Marketing Officer
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and e-retail technologies in the Health and Wellness space, is pleased to announce a brief operational update on progress and the appointment of a Senior Marketing Officer.
Oct 27, 2017 03:21 pm ET
Relevium Provides Operational Progress Update and Appoints Senior Marketing Officer
Relevium Technologies Inc.  (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on creating value through the acquisition and development of e-brands, online businesses and...
Oct 25, 2017 08:30 am ET
Relevium Signs LOI to Acquire Nutraceutical Brand
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on the acquisition and building of e-retail brands, products and technologies in the health and wellness market, is pleased to announce that it has signed a non-binding Letter Of Intent (the "LOI") to acquire an American based nutraceutical brand that sells products direct to consumers primarily through the Amazon.com channel in the Vitamins and Dietary Supplements category. The transaction value is currently estimated
Oct 25, 2017 08:28 am ET
Relevium Signs LOI to Acquire Nutraceutical Brand
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on the acquisition and building of e-retail brands, products and technologies in the health and...
Oct 20, 2017 03:34 pm ET
Relevium Changes Auditors and Corporate Update
Relevium Technologies Inc. (TSX VENTURE:RLV) and (FRANKFURT:6BX) (the "Company" or "Relevium") announced today that it has changed auditors and appointed Ernst & Young LLP, Chartered Professional Accountants, as the Company's new auditor...
Oct 20, 2017 03:34 pm ET
Relevium Changes Auditors and Corporate Update
Relevium Technologies Inc. (TSX VENTURE: RLV) and (FRANKFURT: 6BX) (the "Company" or "Relevium") announced today that it has changed auditors and appointed Ernst & Young LLP, Chartered Professional Accountants, as the Company's new auditor (the "Successor Auditor"), replacing Nexia Freedman LLP, Chartered Professional Accountants (the "Former Auditor"). At the request of the Company, the Former Auditor has resigned and the Successor Auditor has been appointed as of the effective date of October 11, 2017.
Sep 28, 2017 08:00 am ET
Relevium Creates Alliance With Salavenia Nutrition and Biodevas Laboratoires to Develop an Exclusive Line of Phyto and Nutraceuticals for Pets
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to announce the launch of a joint cooperation with Salvenia Nutrition and Biodevas Laboratoires to develop an exclusive brand and product line of nutraceuticals and phytoceuticals targeted to Pet Care owners on a direct to consumer basis. Product and market development initiatives are expected to begin in October of this year with the objective of a preliminary launch by Spring of 2018 as a wholly-owned subsidiary of Relevium.
Sep 28, 2017 07:58 am ET
Relevium Creates Alliance With Salavenia Nutrition and Biodevas Laboratoires to Develop an Exclusive Line of Phyto and Nutraceuticals for Pets
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce the launch of a joint cooperation with Salvenia Nutrition and Biodevas Laboratoires to develop an exclusive brand and product line of...
Sep 07, 2017 12:00 pm ET
Relevium Launches First Stage Big Data & AI Project and Engages agileDSS Inc.
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on the acquisition and building of e-retail brands, products and technologies in the health and wellness market, is pleased to announce the kickoff of its maiden technology build.
Sep 07, 2017 11:58 am ET
Relevium Launches First Stage Big Data & AI Project and Engages agileDSS Inc.
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), a publicly traded corporation strategically focused on the acquisition and building of e-retail brands, products and technologies in the health and wellness...
Aug 02, 2017 08:00 am ET
Relevium Reports Revenue Growth in the First 50 Days of Business and Guidance Update
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a publicly traded corporation strategically focused on the acquisition of e-retail brands, products and technologies in the health and wellness market is pleased to provide guidance on its strategy and focus for the balance of calendar year 2017.
Aug 02, 2017 07:58 am ET
Relevium Reports Revenue Growth in the First 50 Days of Business and Guidance Update
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a publicly traded corporation strategically focused on the acquisition of e-retail brands, products and technologies in the health and wellness market is...
Jun 22, 2017 10:12 am ET
Relevium Provides Corporate Update and Final Closing of the Equity Financing
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide a corporate update on its recent acquisition of BioGanix and the closing of...
Jun 22, 2017 10:12 am ET
Relevium Provides Corporate Update and Final Closing of the Equity Financing
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide a corporate update on its recent acquisition of BioGanix and the closing of the final tranche o of the equity financing.
Jun 12, 2017 01:18 pm ET
IIROC Trading Resumption - RLV
VANCOUVER, June 12, 2017 /CNW/ - Trading resumes in:
Jun 12, 2017 11:56 am ET
Relevium Completes Acquisition of BioGanix and Initial Closing of Concurrent Debt and Equity Financing
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce that it has completed the acquisition of all of the business and...
Jun 12, 2017 11:55 am ET
Relevium Completes Acquisition of BioGanix and Initial Closing of Concurrent Debt and Equity Financing
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce that it has completed the acquisition of all of the business and assets of BioGanix Ltd. as well as the initial closing of its concurrent debt and equity financing.
Jun 06, 2017 06:08 pm ET
IIROC Trading Halt - RLV
VANCOUVER, June 6, 2017 /CNW/ - The following issues have been halted by IIROC:
May 18, 2017 06:25 pm ET
Relevium Provides Update on Financing and Acquistion of BioGanix
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide an update on the acquisition of BioGanix and the related financing.
May 18, 2017 06:25 pm ET
Relevium Provides Update on Financing and Acquistion of BioGanix
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide an update on the acquisition of BioGanix and the related financing....
May 10, 2017 11:05 am ET
Relevium & Hempco Sign Exclusive Relationship for e-Commerce Retail of Hemp Nutrition and Nutraceutical Products
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness together with Hempco Food and Fiber Inc. (TSX VENTURE:HEMP) ("Hempco®") announced today an...
May 10, 2017 11:05 am ET
Relevium & Hempco Sign Exclusive Relationship for e-Commerce Retail of Hemp Nutrition and Nutraceutical Products
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness together with Hempco Food and Fiber Inc. (TSX VENTURE: HEMP) ("Hempco(R)") announced today an agreement for cooperation to develop a complete hemp based nutraceutical and nutritional product line for exclusive distribution through the future Relevium portfolio of brands through global E-Commerce platforms such as Amazon and Jet.com.
May 02, 2017 11:05 am ET
Relevium Secures Improved Terms for BioGanix Acquisition and Receives Commitment Letter for Secured Convertible Debenture
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce that it has secured a more flexible structure for the definitive asset purchase agreement (as announced on April 10, 2017) for the BioGanix acquisition. The company is also pleased to announce it has received a commitment letter from AIP Asset Management and AIP Private Capital for a total of $2.25M in secured convertible debentures.
May 02, 2017 11:05 am ET
Relevium Secures Improved Terms for BioGanix Acquisition and Receives Commitment Letter for Secured Convertible Debenture
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce that it has secured a more flexible structure for the definitive asset...
May 01, 2017 07:32 am ET
Relevium Provides Corporate Update on BioGanix Acquisition
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide its shareholders with an update on the acquisition of BioGanix.
May 01, 2017 07:32 am ET
Relevium Provides Corporate Update on BioGanix Acquisition
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide its shareholders with an update on the acquisition of BioGanix. As...
Apr 12, 2017 09:30 am ET
Relevium announces 2017 AGM results
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce the positive results from its Annual General Meeting ("AGM") held on April 7,...
Apr 12, 2017 09:30 am ET
Relevium announces 2017 AGM results
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce the positive results from its Annual General Meeting ("AGM") held on April 7, 2017 in Montreal, QC.
Apr 10, 2017 12:57 pm ET
Relevium Executes Definitive Agreement to Acquire BioGanix
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness announced today that pursuant to the announcement made on December 22, 2016 and March 20, 2017, the Company executed a definitive agreement ("the APA") for the transaction to acquire BioGanix Limited ("BGL").
Apr 10, 2017 12:56 pm ET
Relevium Executes Definitive Agreement to Acquire BioGanix
Relevium Technologies Inc.  (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness announced today that pursuant to the announcement made on December 22, 2016 and March 20,...
Mar 20, 2017 10:10 am ET
Relevium Provides Corporate Update on the Transaction to Acquire Bioganix
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide an update regarding the acquisition of BioGanix Limited ("BGL")....
Mar 20, 2017 10:10 am ET
Relevium Provides Corporate Update on the Transaction to Acquire Bioganix
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide an update regarding the acquisition of BioGanix Limited ("BGL").
Mar 13, 2017 05:12 pm ET
Relevium Receives Conditional Acceptance on the Transaction to Acquire BioGanix
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce that, further to the Company's news release of December 22, 2016 the...
Mar 13, 2017 05:12 pm ET
Relevium Receives Conditional Acceptance on the Transaction to Acquire BioGanix
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce that, further to the Company's news release of December 22, 2016 the Company has received conditional acceptance from the TSX Venture Exchange (the "Exchange") regarding a binding letter of intent (the "LOI") to acquire the assets of BioGanix Limited ("BGL"), a privately- held nutraceutical company in Houston, Texas focused on heart, brain, digestive health and joint
Feb 22, 2017 11:10 am ET
IIROC Trading Resumption - RLV
VANCOUVER, Feb. 22, 2017 /CNW/ - Trading resumes in:
Feb 22, 2017 11:03 am ET
Relevium Announces Private Placement and Provides Update on BioGanix Acquisition
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide the following update to its press release of December 22, 2016 announcing...
Feb 22, 2017 11:03 am ET
Relevium Announces Private Placement and Provides Update on BioGanix Acquisition
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to provide the following update to its press release of December 22, 2016 announcing a binding letter of intent (the "LOI") to acquire the assets of BioGanix Limited ("BGL"), a privately-held nutraceutical company in Houston, Texas focused on heart, brain, digestive health and joint support products sold through primarily through e-commerce platforms.
Feb 22, 2017 09:20 am ET
IIROC Trading Halt - RLV
VANCOUVER, Feb. 22, 2017 /CNW/ - The following issues have been halted by IIROC:
Feb 10, 2017 11:46 am ET
Dr. Tina Sampalis M.D., Ph.D. Joins Relevium's Board of Directors
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness in conjunction with its board of directors, is pleased to announce the addition of Dr. Tina Sampalis to the Company's Board of Directors.
Feb 10, 2017 11:46 am ET
Dr. Tina Sampalis M.D., Ph.D. Joins Relevium's Board of Directors
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness in conjunction with its board of directors, is pleased to announce the addition of Dr. Tina Sampalis...
Feb 01, 2017 08:00 am ET
Relevium Provides Update on Binding Agreement
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX)(the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness announced on December 22, 2016 it had executed a binding letter of intent (the "LOI") to acquire the assets of BioGanix Limited ("BGL"), a privately- held nutraceutical company in Houston, Texas focused on heart, brain, digestive health and joint support products sold through primarily through e-commerce platforms.
Feb 01, 2017 07:58 am ET
Relevium Provides Update on Binding Agreement
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX)(the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness announced on December 22, 2016 it had executed a binding letter of intent (the "LOI") to acquire the...
Jan 26, 2017 10:21 am ET
IIROC Trading Resumption - RLV
VANCOUVER, Jan. 26, 2017 /CNW/ - Trading resumes in:
Jan 25, 2017 12:20 pm ET
Relevium provides corporate update and lifting of stock halt
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX)(the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness announced on December 22, 2016 it had executed a binding letter of intent (the "LOI") to acquire the...
Jan 25, 2017 12:20 pm ET
Relevium provides corporate update and lifting of stock halt
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX)(the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness announced on December 22, 2016 it had executed a binding letter of intent (the "LOI") to acquire the assets of BioGanix Limited ("BGL"), a privately- held nutraceutical company in Houston, Texas focused on heart, brain, digestive health and joint support products sold through primarily through e-commerce platforms.
Jan 12, 2017 03:26 pm ET
Relevium Provides Update on BioGanix and Trading Halt
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium"), a consolidator of e-commerce assets in Health and Wellness, announced on December 22, 2016 that it had executed a binding letter of intent (the "LOI") to...
Jan 12, 2017 03:26 pm ET
Relevium Provides Update on BioGanix and Trading Halt
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium"), a consolidator of e-commerce assets in Health and Wellness, announced on December 22, 2016 that it had executed a binding letter of intent (the "LOI") to acquire the assets of BioGanix Limited ("BGL"), a privately- held nutraceutical company based in Houston, Texas and focused on heart, brain, digestive health and joint support products sold through primarily through e-commerce platforms.
Dec 22, 2016 09:00 am ET
Relevium Signs Binding LOI to Acquire Nutraceutical Asset With US$ 1.3 Million in EBITDA
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce today it has executed a binding letter of intent (the "LOI") to acquire the assets of BioGanix Limited ("BGL"), a privately- held nutraceutical company in Houston, Texas focused on heart, brain, digestive health and joint support products sold through primarily through e-commerce platforms.
Dec 22, 2016 08:58 am ET
Relevium Signs Binding LOI to Acquire Nutraceutical Asset With US$ 1.3 Million in EBITDA
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") a consolidator of e-commerce assets in Health and Wellness is pleased to announce today it has executed a binding letter of intent (the "LOI") to acquire the...
Dec 21, 2016 03:24 pm ET
IIROC Trading Halt - RLV
VANCOUVER, Dec. 21, 2016 /CNW/ - The following issues have been halted by IIROC:
Nov 08, 2016 08:00 am ET
Relevium Appoints Advisory Board
Relevium Technologies Inc. (TSX VENTURE: RLV) and (FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to announce the appointment of Martin M. Scullion and Quinn Roukema to the Advisory Board of the Corporation.
Nov 08, 2016 07:58 am ET
Relevium Appoints Advisory Board
Relevium Technologies Inc. (TSX VENTURE:RLV) and (FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce the appointment of Martin M. Scullion and Quinn Roukema to the Advisory Board of the Corporation. Mr. Martin M. Scullion,...
Nov 03, 2016 08:00 am ET
Relevium to Launch Relevium Wellness and Relevium E-Health
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to announce the launch of two wholly-owned subsidiaries: Relevium Wellness Inc. and Relevium E-Health Inc.
Nov 03, 2016 07:58 am ET
Relevium to Launch Relevium Wellness and Relevium E-Health
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce the launch of two wholly-owned subsidiaries: Relevium Wellness Inc. and Relevium E-Health Inc. Relevium Wellness Inc. is a...
Oct 25, 2016 12:14 am ET
Relevium Announces Changes in Management
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") today announced the appointment of Aurelio Useche as President and CEO, effective November 1st, 2016.  Mr. Useche, who currently serves on the...
Oct 25, 2016 12:14 am ET
Relevium Announces Changes in Management
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") today announced the appointment of Aurelio Useche as President and CEO, effective November 1st, 2016.
Oct 18, 2016 04:23 pm ET
Relevium Completes Maestro Private Placement
Relevium Technologies Inc. (TSX VENTURE:RLV) (FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to announce it has completed the previously announced private placement by Maestro Capital Corporation (the "Private Placement"). On July...
Oct 18, 2016 04:23 pm ET
Relevium Completes Maestro Private Placement
Relevium Technologies Inc. (TSX VENTURE: RLV) (FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to announce it has completed the previously announced private placement by Maestro Capital Corporation (the "Private Placement").
Sep 27, 2016 07:00 am ET
Relevium Provides Corporate Update
Relevium Technologies Inc. (TSX VENTURE: RLV)(FRANKFURT: 6BX) (the "Company" or "Relevium") is pleased to provide the following corporate update on its ongoing activities.
Sep 27, 2016 06:58 am ET
Relevium Provides Corporate Update
Relevium Technologies Inc. (TSX VENTURE:RLV)(FRANKFURT:6BX) (the "Company" or "Relevium") is pleased to provide the following corporate update on its ongoing activities. UPDATE ON PRIVATE PLACEMENT As announced on August 19,...